Previous Article | Next Article ![]()
Infect. Immun., 12 1997, 4904-4908, Vol 65, No. 12
J Barbic, MF Leef, DL Burns and RD Shahin
Using a mouse model of Bordetella pertussis infection, we have analyzed the
role of gamma interferon (IFN-gamma) in bacterial clearance from the
respiratory tract. Adult BALB/c mice began to clear a respiratory infection
within 3 weeks postinfection, with complete resolution of infection 6 to 8
weeks postinfection. In contrast, neither adult SCID mice (which lack
mature B and T lymphocytes) nor adult nude mice (which lack mature T
lymphocytes) controlled B. pertussis infection, and both strains died
within 3 to 5 weeks postinfection. Short-term T-cell lines generated from
the draining lymph nodes of the lungs of infected BALB/c mice were found to
be CD4+ and produced IFN-gamma but no detectable interleukin-4. Analyses of
IFN-gamma mRNA induction in the lungs of mice following B. pertussis
infection showed that in both BALB/c and C57BL/6 mice, IFN-gamma mRNA
levels increased sharply by 1 week postinfection and then subsequently
declined. Further exploration of a potential role for IFN-gamma
demonstrated that infection of adult BALB/c mice depleted of IFN-gamma in
vivo with anti-IFN-gamma monoclonal antibodies resulted in greater numbers
of bacteria recovered from the lungs than in infected, control BALB/c mice,
although IFN- gamma-depleted mice could subsequently clear the infection.
Infection of mice which have a disrupted IFN-gamma gene resulted in
bacterial clearance with a time course similar to those seen with
IFN-gamma- depleted mice. These results indicate that IFN-gamma plays a
role in controlling B. pertussis infection.
Copyright © 1997, American Society for Microbiology
Role of gamma interferon in natural clearance of Bordetella pertussis infection
Laboratory of Pertussis, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|